Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation.
Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation. Am J Respir Crit Care Med. 2002 May 15; 165(10):1433-8.
View in:
PubMed
subject areas
Administration, Intranasal
Administration, Intranasal
Analysis of Variance
Analysis of Variance
Animals
Animals
Chemokine CCL5
Chemokine CCL5
Disease Models, Animal
Disease Models, Animal
Female
Female
Fluorocarbons
Fluorocarbons
Hydrocarbons, Brominated
Hydrocarbons, Brominated
Immunohistochemistry
Immunohistochemistry
Mice
Mice
Mice, Inbred BALB C
Mice, Inbred BALB C
NF-kappa B
NF-kappa B
Pneumonia, Viral
Pneumonia, Viral
Probability
Probability
Random Allocation
Random Allocation
Reference Values
Reference Values
Respiratory Syncytial Virus Infections
Respiratory Syncytial Virus Infections
Respiratory Tract Infections
Respiratory Tract Infections
RNA, Messenger
RNA, Messenger
Sensitivity and Specificity
Sensitivity and Specificity
Statistics, Nonparametric
Statistics, Nonparametric